Predicate |
Object |
contentType |
Journal Article |
endingPage |
1059 |
issn |
1535-2900 1079-2082 |
issueIdentifier |
12 |
pageRange |
1059-1059 |
publicationName |
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists |
startingPage |
1059 |
bibliographicCitation |
Traynor K. Linagliptin approved for type 2 diabetes. Am J Health Syst Pharm. 2011 Jun 15;68(12):1059. doi: 10.2146/news110038. PMID: 21642558. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0c6d81566145f8b2698799c29ebdf8d |
date |
2011-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/21642558 https://doi.org/10.2146/news110038 |
isPartOf |
https://portal.issn.org/resource/ISSN/1535-2900 https://portal.issn.org/resource/ISSN/1079-2082 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8629 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Linagliptin approved for type 2 diabetes |
discusses |
http://id.nlm.nih.gov/mesh/M0554626 http://id.nlm.nih.gov/mesh/M0508515 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0018169 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D017277 http://id.nlm.nih.gov/mesh/D011687Q000627 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D011799Q000627 http://id.nlm.nih.gov/mesh/D054873Q000627 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D002986 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000069476 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10096344 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 |